Education
About Us
Working with TipRanks
Follow Us
John Patrick Shannon Insider Profile
18 Followers
John Patrick Shannon, CCO at Durata, holds 2.66M shares in Xeris Pharmaceuticals (Ticker: XERS), holds 0.00 shares in Durata (Ticker: DRTX).
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+11.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John Patrick Shannon's holdings
Insider Roles
CEO and Director, Director
Roles that John Patrick Shannon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 17, 2023 - Nov 17, 2024
Return:+64.90%
The most profitable trade made by John Patrick Shannon
John Patrick Shannon's Trading History
Durata
Nov 18, 2014
―
Uninformative Sell
―
―
Xeris Pharmaceuticals
Aug 04, 2025
CEO and Director, Director
Uninformative Sell
198.62K
$21.23M
List of latest transactions for each holding click on a transaction to see John Patrick Shannon's performance on stock
You May Also Like
John Patrick Shannon insider profile FAQ
What is the percentage of profitable transactions made by John Patrick Shannon?
The percentage of profitable transactions made by John Patrick Shannon is 40%.
What is the average return per transaction made by John Patrick Shannon?
The average return per transaction made by John Patrick Shannon is 11.80%.
What stocks does John Patrick Shannon hold?
John Patrick Shannon holds: DRTX, XERS stocks.
What was John Patrick Shannon’s latest transaction?
John Patrick Shannon latest transaction was an Uninformative Sell of $198.62K.
What was John Patrick Shannon's most profitable transaction?
John Patrick Shannon’s most profitable transaction was an Informative Buy of XERS stock on November 17, 2023. The return on the trade was 64.90%.
What is John Patrick Shannon's role in Durata?
John Patrick Shannon's role in Durata is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.